Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-09-21 00:00:00 ET · period of report 2022-09-19 · accession 0001127602-22-022778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-21 | 2022-09-19 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $51.42 | -10.0K | 406.1K | -2% | -$514.2K |
| D | 2022-09-21 | 2022-09-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 416.1K | +2% | +$79.6K |
| D | 2022-09-21 | 2022-09-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $0.00 | -10.0K | 29.2K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-19 | S | D | 10,000 | $51.42 | 406,089 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-19 | M | A | 10,000 | $7.96 | 416,089 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-09-19 | M | D | 10,000 | $0.00 | 29,208 | D | $7.96 · 2015-03-26 to 2025-02-26 | 10,000 Common Stock |